Fundraising FoxTheraclion
France corporation · 2 known investors
Find your way into Theraclion
Sign up to see every warm intro you have to Theraclion
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Theraclion team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Theraclion develops ultrasound-based medical devices for non-invasive treatment of vascular and thyroid conditions. The company designs robotic platforms combining ultrasound imaging and robotics for patients seeking alternatives to surgery.
Founders & leadership
SA
Sarah AnkriChief Financial Officer / Directrice Financière2013–2015Sarah Ankri was a partner at EY France in Financial Accounting Advisory Services, with expertise in legal audit, due diligence, and fundraising. She is Executive Officer of Theraclion, which develops ultrasound-based robotic platforms for non-invasive treatment of vascular and thyroid conditions.
AK
Anja KleberChief Business Development Officer2014–2023Anja Kleber is an Executive Officer at Theraclion, a medical device company developing ultrasound-based robotic platforms for non-invasive treatment of vascular and thyroid conditions. She brings experience across medical specialties including oncology, radiotherapy, and endocrinology, with expertise in medtech commercialization, business development, and international markets.
DC
David CaumartinExecutiveDavid Caumartin spent 15 years at GE Healthcare managing a global imaging business and launching diagnostic platforms across multiple regions, followed by 8 years as CEO of Theraclion, where he scaled the focused ultrasound company to treat thousands of patients and raised over €50 million before pivoting the business strategy. He currently serves as CEO of RebrAIn, an FDA-cleared neurosurgery software company, and as a senior partner with the Focused Ultrasound Foundation.
Board
PP
Phillippe PoulettyBoard director
BV
Bern Von PolheimBoard director
LL
Laurent LevyBoard director
FL
Francois LaCosteBoard director
JB
Jean-Yves BurelBoard director
VG
Vincent GardesBoard director
Investors · 2
Karistalisted by KaristaParis · $324K – $5.4M
How we know: Karista's portfolio page · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$250K disclosed across 1 round · 2015
▶$250KraisedJul 2015 · 1 investors · BiotechnologyRule 506(b)
▶$250KraisedJul 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michel NutaExecutive Officer
- Bern Von PolheimDirector
- Sarah AnkriExecutive Officer
- Laurent LevyDirector
- Sylvain YonExecutive Officer
- Francois LaCosteDirector
- Anja KleberExecutive Officer
- Jean-Yves BurelDirector
- David CaumartinExecutive Officer
- Phillippe PoulettyDirector
- Vincent GardesDirector
- Offering amount
- $250K
- Amount sold
- $250K
- Sales commissions
- $12.5K
- Placement agents
- LifeSci Capital LLC
- First sale
- Jun 2015
- Incorporated
- Corporation, France
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Theraclion went on to found or lead other companies.
Related companies · 5
Boston ScientificBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
AccuVeinAccuVein manufactures vein visualization systems for medical professionals to locate veins during procedures. The company serves healthcare providers in clinical and procedural settings.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
ReflexionmedicalRefleXion Medical develops SCINTIX autonomous radiotherapy, an external beam theranostic oncology platform that uses biological signals from radiopharmaceutical-labeled cancer cells to deliver real-time, motion-managed radiation to lung and bone tumors from primary or metastatic disease. The technology is used by cancer treatment centers, including freestanding cancer centers and hospital outpatient departments, to treat solid tumors at any stage.
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Companies working in the same space as Theraclion.
Frequently asked questions
- What does Theraclion do?
- Theraclion develops ultrasound-based medical devices for non-invasive treatment of vascular and thyroid conditions. The company designs robotic platforms combining ultrasound imaging and robotics for patients seeking alternatives to surgery.
- Who are Theraclion's investors?
- Theraclion's investors include CapDecisif Management, Karista.
- How much funding has Theraclion raised?
- Theraclion has disclosed $250K raised across 1 round.